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I n 8 p a t . f i n a 1 h e i g h t i s -0.68SD when a d u l t h e i g h t p r e d i c t e d a t
d i a g n o s i s was +0.32SD. Growth impairment was determined by t h e f o l l o w i n g : 1 ) d u r a t i o n o f chemotherapy: 5 y r s a f t e r diagnosis,mean h e i g h t SDS f o r CA was reduced by -0.65 SD and by -1.01 SD r e s p e ct i v e l y i n p a t i e n t s t r e a t e d f o r 2 and f o r 5 y r s . 2 ) R a d i a t i o n d o s e s : 5 y r s a f t e r d i a g n o s i s mean h e i g h t SDS f o r CA was reduced by -0.34 SD and by -1.14 SD i n t h o s e r e c e i v i n g 18 Gy and 24 Gy r e s p e c t i v e l y . 3 ) Lack o f catch-up growth a f t e r t h e r a p y : between end of therapy and o n s e t of p u b e r t y , h e i g h t SDS f o r CA d i d n o t change (-0.06 SD). I n 16/33 e u t h y r o i d p a t . e v a l u a t e d a t l e a s t 2 y r s a f t e r i r r a d i a t i o r GI1 r e s p o n s e was b l u n t e d (110 n g l m l ) i n 2 pharmacolbgical t e s t s .
I n 11/30 Sm-C was low f o r CA. No hGll t r e a t m e n t was given. 4 ) E a r l y p u b e r t y i n r e l a t i o n t o age a t d i a g n o s i s : i n g i r l s diagnosed b e f o r e o r a f t e r age 7, M s t a r t e d r e s p e c t i v e l y a t mean CA o f 10.6 y r s (n=16) and 11.4(n=15$, a c c o u n t i n g f o r a d i f f e r e n c e of -0.4 SD i n h e i g h t f o r CA a t p u b e r t y . 5 ) Reduction of p u b e r t a l growth s p u r t : compared t o a v e r a g e normal g i r l s , mean p u b e r t a l h e i g h t g a i n was reduced by 3 , 8 cm. P i t u i t a r y -g o n a d a l f u n c t i o n ( G n R l t t e s t , n=30) was normal. Conclusion : I n ALL p a t . growth impairment h a s s c v e r a l components, d i f f e r i n g by time of o c c u r r e n c e and mechanism.
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GROklH HORMONE (GH) DIRECTLY ENHANCES CHONDROGENESIS AND OSTEOGENESIS IN VITRO.

To s t u d y t h e d i r e c t e f f e c t of GH on c h o n d r o g e n e s i s and o s t e o g
e n esis 2 model s y s t e m s were used.An o r g a n c u l t u r e o f newborn mice m a n d i b u l a r c o n d y l e were m a i n t a i n e d on c o l l a g e n o u s sponge, cemented onto stainless steel mesh f o r 6 days. The a d d i t i o n o f 50 ng/ml r e c o m b i n a n t human GH (hGH) caused w i t h i n 3 d a y s a marked e n l a r g ement o f t h e p r o l i f e r a t i v e zone from 5 6 i 6 t o 120511 microns.
The w i d t h o f t h e c h o n d r o b l a s t l a y e r i n c r e a s e d by hGH from 6659 t o 199+7 m i c r o n s , r e f l e c t i n g s i g n i f i c a n t p r o l i f e r a t i o n , and t h a t o f t h e c h o n d r o c y t i c l a y e r from 288222 t o 465+9 m i c r o n s , r e f l e c t i n g
d i f f e r e n t i a t i o n . The c a l c i f i e d c a r t i l a g e s h r a n k from 400212 t o 333529 microns. I n a s e p a r a t e tissue c u l t u r e system o f mice c h o n d r o p r o g e n i t o r cells, t h e u n d i f f e r e n t i a t e d cells developed w i t h i n 3 d a y s t o a c a r t i l a g e nodule which by 6 d a y s grew f u r t h e r . , and t h a t o f t h e c a r t i l a g e l a y e r from 242210 t o 477212 microns. Moreover, under hGH we obs e r v e d t h e a p p e a r a n c e o f c a l c i f i e d c a r t i l a g e and o s t e o g e n e s i s o f bone t r a b e c u l e s , o s t e o c y t e s , o s t e o b l a s t s and osteoclasts, which were a b s e n t i n t h e a b s e n c e o f hGH. W e c o n c l u d e t h a t hGH h a s a d i r e c t e f f e c t on c h o n d r o g e n e s i s and o s t e o g e n e s i s i n tissue and o r g a n c u l t u r e , which are both p r o l i f e r a t i v e and d i f f e r e n t i a t i v e .
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Departments o f Haematology and Growth & Development, I n s t i t u t c o f C h i l d H e a l t h , London WCl lEH, UK. PRECOCIOUS OR EARLY PUBERTY AND GROWTH FAILURE IN GIRLS TREATED FOR ACUTE LYMPIIOBLASTIC LEUKAEMIA. W c have s t u d i c d 31 g i r l s w i t h ALL who have bccn t r c a t e d w i t h p r o p h y l a c t i c 1800 -2400 cGy t o t h e . c r a n i a 1 meninees; 3 g i r l s had f u r l h c r c r a n i a l i r r a d i a t i o n f o l l o w i n g r e l a p s e . A l l had been t r e a t e d w i t h i n t r a t h e c a l M e t h o t r e x a t c i n a d d i t i o n t o s y s t e m i c chemotherapy.
Mean age o f o n s e t o f p u b e r t y was 8.4 y r s ( r a n g e 6 . 7 -1 0 . 0 ) ; 5 had p r e c o c i o u s p u b e r t y . E a r l y p u b c r t y a s a s c q u c l a e o f p r o p h y l a c t i c low-dose c r a n i a l i r r a d i a t i o n occurcd predominantly i n g i r l s , which i s c o m p a t i b l e w i t h o u r h y p o t h c s i s f o r t h e mechanism o f t h e t i m i n g o f t h e o n s e t o f s e x u a l m a t u r a t i o n .
21 g i r l s had an a b s e n t o r i n a d e q u a t e growth a c c e l e r a t i o n of p u b e r t y . Pharmacological t e s t s o f GH s e c r e t i o n v e r c u n r e l i a b l e a t d i a g n o s i n g GH i n s u f f i c i e n c y , n o t l e a s t bccause s t a n d a r d s f o r GH s e c r e t i o n i n normal p u b c r t y were n o t a v a i l a b l e . E a r l y o r p r c c o c i o u s p u b e r t y combined w i t h GH i n s u f f i c i e n c y may produce s e v e r e growth f a i l u r e and we have used a t r e a t m e n t regimen o f c i t h c r i n L r a n a s a l ( D -s c~~) GnRIl o r Depot ( D -T~~~) GnRll i n combination w i t h b i o s y n t h c t i c Met-GH.
We have been a b l e t o comparc t h c t r e a t m e n t of 10 g i r l s t r c a t c d by t h i s combined regimen f o r up t o 1 . 5 y r s w i t h 19 g i r l s who had no e n d o c r i n e t h c r a p y . The r a t e of advat~ccment of c p i p h y s e a l m a t u r a t i o n slowed and growth r a t e i n c r e a s e d d u r i n g t r e a t m e n t , a l t h o u g h l o n g c r t r c a t m e n t p e r i o d s w i l l be r e q u i r e d t o a s s e s s t h e a f f e c t on f i n a l h e i g h t .
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BLUNTED PUBERTAL G R O W AFTER LEUKEMIA: A NEW PATTERN OF GH-INSUFFICIENCY
G r o w t h a n d a g e at m e n a r c h e w e r e studied i n 10 girls previously treated for A c u t e lymphoblastic leukemia, ALL. These girls h a d n o r m a l prepubertal growth after t r e a t m e n t b u t a subnormal pubertal growth spurt. Their mean final height w a s 1 SD less t h a n expected b e f o r e puberty. The average age at menarche was 12.2 years which is significantely lower (p<0.01) t h a n t h e normal mean for Swedish girls, 13.1 years.
'~~o n t a n e o u s secretion o f Growth hormone, GH, w a s studied during 24 h o u r s i n thirteen girls, 2.9-7.3 years after t h e ending of therapy. Blood samples were t a k e n evely 30 minutes and t h e results were compared with t h e secretion o f normal children. The mean 24-hour secretion for these girls w a s severely blunted a n d t h e r e was no increase i n t h e secretion during puberty. W e suggest that girls w h o have b e e n treated for ALL, including CNSirradiation, have a f o r m of relative GH-insuffiency previously n o t described. This insufEency becomes clinically obvious only w h e n t h e girls cannot respond t o t h e increased d e m a n d s for GH during puberty.
